Cargando…
Repeat radiation with bevacizumab and minocycline in bevacizumab-refractory high grade gliomas: a prospective phase 1 trial
INTRODUCTION: There are no effective treatments for gliomas after progression on radiation, temozolomide, and bevacizumab. Microglia activation may be involved in radiation resistance and can be inhibited by the brain penetrating antibiotic minocycline. In this phase 1 trial, we examined the safety...
Autores principales: | Cohen, Adam L., Anker, Christopher J., Johnson, Brett, Burt, Lindsay M., Shrieve, Dennis C., Salzman, Karen, Jensen, Randy, Boucher, Ken, Colman, Howard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7438283/ https://www.ncbi.nlm.nih.gov/pubmed/32506371 http://dx.doi.org/10.1007/s11060-020-03551-3 |
Ejemplares similares
-
Bevacizumab is Effective for Recurrent Papillary Tumor of the Pineal Region: First Report
por: Cohen, Adam L., et al.
Publicado: (2013) -
Bevacizumab in temozolomide refractory high-grade gliomas: single-centre experience and review of the literature
por: Jeck, Jennifer, et al.
Publicado: (2018) -
Bevacizumab in recurrent WHO grades II–III glioma
por: Annakib, Soufyan, et al.
Publicado: (2023) -
COT-21 EFFECT OF BEVACIZUMAB FOR PEDIATRIC HIGH GRADE GLIOMA
por: Tsukamoto, Yoshihiro, et al.
Publicado: (2019) -
Pulsed Reduced Dose Rate Radiotherapy in Conjunction With Bevacizumab or Bevacizumab Alone in Recurrent High-grade Glioma: Survival Outcomes
por: Bovi, Joseph A., et al.
Publicado: (2020)